Cargando…
Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study
A pandemic designated as Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. Up to date, there is no efficient biomarker for the timely prediction of the disease progression in patients. To analyze the inflammatory profi...
Autores principales: | Yu, Yalan, Liu, Tao, Shao, Liang, Li, Xinyi, He, Colin K., Jamal, Muhammad, Luo, Yi, Wang, Yingying, Liu, Yanan, Shang, Yufeng, Pan, Yunbao, Wang, Xinghuan, Zhou, Fuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671095/ https://www.ncbi.nlm.nih.gov/pubmed/33172355 http://dx.doi.org/10.1080/21505594.2020.1840108 |
Ejemplares similares
-
Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19
por: Shao, Liang, et al.
Publicado: (2020) -
Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer
por: Liu, Guohong, et al.
Publicado: (2018) -
Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus
por: Shang, Yufeng, et al.
Publicado: (2021) -
MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
por: Wu, Balu, et al.
Publicado: (2019) -
Scoring systems for predicting mortality for severe patients with COVID-19
por: Shang, Yufeng, et al.
Publicado: (2020)